Windtree Therapeutics WINT
$ 0.5
-1.65%
Quarterly report 2024-Q2
added 08-19-2024
Windtree Therapeutics Balance Sheet 2011-2024 | WINT
Annual Balance Sheet Windtree Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-2.72 M | -4.14 M | -19.7 M | -14.2 M | -2.81 M | 11.8 M | 13.2 M | 19.4 M | -13.7 M | -24.3 M | -67.8 M | -26.7 M | -9.93 M |
Long Term Debt |
1.16 M | 1.62 M | 2.07 M | 2.42 M | 19.6 M | 15 M | 15 M | 25 M | 25 M | 20.3 M | 18.4 M | 100 K | 200 K |
Long Term Debt Current |
436 K | 404 K | 528 K | 805 K | 750 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 37.2 M | 36.2 M | 30.7 M | 15.5 M | 25.1 M | 25 M | 20.5 M | 18.9 M | 600 K | 1 M |
Total Current Liabilities |
4 M | 2.46 M | 4.92 M | 6.13 M | 7.82 M | 20.6 M | 11.8 M | 13.4 M | 11.1 M | 7.83 M | 11.9 M | 11.7 M | 11.1 M |
Total Liabilities |
29 M | 27.9 M | 32.9 M | 43.3 M | 44 M | 51.3 M | 27.3 M | 38.5 M | 36.1 M | 28.3 M | 30.8 M | 12.3 M | 12.1 M |
Deferred Revenue |
- | - | - | - | - | 198 K | 884 K | - | - | 43 K | 139 K | - | - |
Retained Earnings |
-845 M | -825 M | -785 M | -718 M | -685 M | -658 M | -637 M | -619 M | -579 M | -524 M | -480 M | -435 M | -397 M |
Total Assets |
32.4 M | 38 M | 74.8 M | 113 M | 119 M | 119 M | 3.35 M | 9.7 M | 44.4 M | 47.5 M | 89.3 M | 29.9 M | 13.3 M |
Cash and Cash Equivalents |
4.32 M | 6.17 M | 22.3 M | 16.9 M | 22.6 M | 11.2 M | 1.82 M | 5.59 M | 38.7 M | 44.7 M | 86.3 M | 26.9 M | 10.2 M |
Book Value |
3.39 M | 10 M | 41.9 M | 69.6 M | 74.9 M | 68.1 M | -23.9 M | -28.8 M | 8.27 M | 19.2 M | 58.5 M | 17.6 M | 1.2 M |
Total Shareholders Equity |
3.39 M | 10 M | 41.9 M | 69.6 M | 74.9 M | 68.1 M | -23.9 M | -28.8 M | 8.27 M | 19.2 M | 58.5 M | 17.7 M | 1.26 M |
All numbers in USD currency
Quarterly Balance Sheet Windtree Therapeutics
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
912 K | 1.04 M | 1.16 M | 1.25 M | 1.4 M | 1.51 M | 1.62 M | 1.73 M | 1.84 M | 1.94 M | 2.07 M | 2.2 M | 2.32 M | 2.44 M | 201 K | 201 K | 201 K | 201 K | 794 K | 794 K | 794 K | 794 K | - | - | - | - | - | 12.5 M | 12.5 M | 12.5 M | 25 M | 25 M | 25 M | 25 M | 25 M | 25 M | 25 M | 25 M | 20.3 M | 20.3 M | 20.3 M | 20.3 M | 18.4 M | 18.4 M | 18.4 M | 18.4 M | - | - | - | - | 224 K | 224 K | 224 K | 224 K |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18.3 M | 14.7 M | 29 M | 28.6 M | 29 M | 28.2 M | 27.9 M | 30.7 M | 32.6 M | 32.4 M | 32.9 M | 34.6 M | 34.1 M | 44.4 M | 43.3 M | 43.3 M | 43.3 M | 43.3 M | 44 M | 44 M | 44 M | 44 M | 51.3 M | 51.3 M | 51.3 M | 51.3 M | 27.3 M | 27.3 M | 27.3 M | 27.3 M | 38.5 M | 38.5 M | 38.5 M | 38.5 M | 36.1 M | 36.1 M | 36.1 M | 36.1 M | 28.3 M | 28.3 M | 28.3 M | 28.3 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 158 K | 198 K | 503 K | 731 K | 884 K | 884 K | 1.07 M | - | 884 K | - | - | - | - | - | - | - | - | 43 K | 43 K | 43 K | 43 K | 139 K | 139 K | 139 K | 139 K | - | - | - | - | - | - | - | - |
Retained Earnings |
-847 M | -835 M | -845 M | -840 M | -835 M | -829 M | -825 M | -815 M | -811 M | -793 M | -785 M | -772 M | -764 M | -727 M | -718 M | -718 M | -718 M | -718 M | -685 M | -685 M | -685 M | -685 M | -658 M | -658 M | -658 M | -658 M | -637 M | -637 M | -637 M | -637 M | -619 M | -619 M | -619 M | -619 M | -579 M | -579 M | -579 M | -579 M | -524 M | -524 M | -524 M | -524 M | -480 M | -480 M | -480 M | -480 M | -435 M | -435 M | -435 M | -435 M | -397 M | -397 M | -397 M | -397 M |
Total Assets |
28.7 M | 30.1 M | 32.4 M | 36.1 M | 40.6 M | 35.2 M | 38 M | 48.1 M | 51.8 M | 67.1 M | 74.8 M | 84.8 M | 90.9 M | 136 M | 113 M | 113 M | 113 M | 113 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | 3.35 M | 3.35 M | 3.35 M | 3.35 M | 9.7 M | 9.7 M | 9.7 M | 9.7 M | 44.4 M | 44.4 M | 44.4 M | 44.4 M | 47.5 M | 47.5 M | 47.5 M | 47.5 M | 89.3 M | 89.3 M | 89.3 M | 89.3 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 13.3 M | 13.3 M | 13.3 M | 13.3 M |
Cash and Cash Equivalents |
1.8 M | 2.55 M | 4.32 M | 7.36 M | 11.5 M | 4.24 M | 6.17 M | 8.44 M | 11.4 M | 15.5 M | 22.3 M | 24.5 M | 30 M | 38.5 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 1.82 M | 1.82 M | 1.82 M | 1.82 M | 5.59 M | 5.59 M | 5.59 M | 5.59 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M | 44.7 M | 44.7 M | 44.7 M | 44.7 M | 86.3 M | 86.3 M | 86.3 M | 86.3 M | 26.9 M | 26.9 M | 26.9 M | 26.9 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M |
Book Value |
10.4 M | 15.4 M | 3.39 M | 7.48 M | 11.6 M | 7.03 M | 10 M | 17.4 M | 19.2 M | 34.7 M | 41.9 M | 50.2 M | 56.8 M | 91.5 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 74.9 M | 74.9 M | 74.9 M | 74.9 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | -23.9 M | -23.9 M | -23.9 M | -23.9 M | -28.8 M | -28.8 M | -28.8 M | -28.8 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 58.5 M | 58.5 M | 58.5 M | 58.5 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 1.26 M | 1.26 M | 1.26 M | 1.26 M |
Total Shareholders Equity |
3.49 M | 15.4 M | 3.39 M | 7.48 M | 11.6 M | 7.03 M | 10 M | 17.4 M | 19.2 M | 34.7 M | 41.9 M | 50.2 M | 56.8 M | 91.5 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 74.9 M | 74.9 M | 74.9 M | 74.9 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | -23.9 M | -23.9 M | -23.9 M | -23.9 M | -28.8 M | -28.8 M | -28.8 M | -28.8 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 19.2 M | 19.2 M | 19.2 M | 19.2 M | 58.5 M | 58.5 M | 58.5 M | 58.5 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 1.26 M | 1.26 M | 1.26 M | 1.26 M |
All numbers in USD currency